Mateusz Kaczmarek, Author at TechStock²

Disney Stock Could Soar? Analysts Pin 20% Upside on Streaming Shake-Up and Park Growth

Steady Stock Performance, Mixed Trends Disney’s share price has been relatively flat in 2025 after rallying in 2024. As of Oct. 17 the stock sat around $110.7 marketbeat.com, roughly unchanged from early January. Over the last few days DIS has

18 October 2025

Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple’s stock is trading near record levels as of mid-October 2025. Last week (Oct. 13–17), AAPL shares oscillated in the $247–$252 range, closing at $252.29 on Oct. 17 historicalstockprice.com. That is only a few dollars below the all-time intraday high (~$260) set

18 October 2025

Apple · Artificial Intelligence · Investing · Stocks · Technology

GE Aerospace Stock Rockets as Rally Continues – Q3 Earnings, Contracts, and Analyst Targets in Focus

Surging Stock Performance GE Aerospace (NYSE: GE) shares have been on a tear in 2025, roughly doubling from lows. As of Oct 17, 2025, the stock closed around $300 reuters.com. That’s up about 78% this year intelligentinvestor.com.au – one of

18 October 2025

Aerospace · Earnings Reports · Investment News · Market Analysis · NYSE:GE · Stocks

IBM Stock Rockets 28%: AI Boom, Quantum Breakthroughs & Big Deals Spark Rally

Recent Stock Rally Driven by AI and Quantum News IBM’s stock has rallied sharply in fall 2025. It closed around $279 on Oct 13 ts2.tech, just shy of its late-September peak near $296 ts2.tech. Investors point to IBM’s pivot to

18 October 2025

AI Innovation · Financial News · NYSE:IBM · Quantum Computing · Stock Market · Technology

Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Stock Surge & Analyst Reaction Atai shares exploded higher on Oct. 17, 2025. Investors bid the stock up ~17.7%, closing at roughly $6.45 ts2.tech (versus ~$5.48 offering price). In after-hours trading it briefly touched ~$6.86 ts2.tech. This rally follows a

18 October 2025

Biotech · FDA Approval · Investments · NASDAQ:ATAI · Psychedelics · Stock Market

Cisco Stock Surges Near 52-Week High on AI Momentum – What’s Next for CSCO?

CSCO Stock Climbs on Strong Quarter: Cisco’s stock has steadily climbed in 2025, even as many tech peers swung wildly during the AI frenzy. As of mid‑October, CSCO is trading just below its year-high ts2.tech ts2.tech. Over the past week

18 October 2025

Artificial Intelligence · Financial News · Investing · NASDAQ:CSCO · Stock Market · Technology

New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

Key Stock Metrics: Metric Value (as of Oct 17, 2025) Closing Price $4.55 investing.com 1-Day Change +44.4% (vs $3.15 prev. close) stockanalysis.com Day’s Range $3.20 – $4.71 stockanalysis.com Volume (Oct 17) 33.82 million stockanalysis.com Market Cap ~$129.3 million investing.com 52-Week

18 October 2025

Artificial Intelligence · Energy Sector · Financial News · Investment Analysis · Stock Market

MindMed Stock Rockets on Breakthrough LSD Anxiety Data – Analysts Eye 100% Upside

Stock Soars on Catalyst News MindMed’s stock has skyrocketed in recent weeks. After languishing in the single digits, MNMD climbed above $12 in late September and spiked to $13.09 on Oct. 14, its highest level in over a year ts2.tech

18 October 2025

Biotech · Investing · Market News · Mental Health · NASDAQ:MNMD · Stocks

Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

SPCE’s October Volatility: Surge and Selloff In mid-October 2025, Virgin Galactic’s stock was a top mover in the market. After languishing in the low-$3 range, SPCE shares rallied over 40% in early October on a wave of positive news ts2.tech.

18 October 2025

Investing · Market Trends · NYSE:SPCE · Space Tourism · Stock Market · Technology

Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Stock Price and Performance As of mid-October 2025, Sellas Life Sciences (NASDAQ:SLS) trades around $2.10–2.20. This is near the top of its 52-week range ($0.77 low) and about twice its price at the start of 2025 stockanalysis.com marketbeat.com. Trading volume

18 October 2025

Biotechnology · Investment Analysis · Leukemia Research · NASDAQ:SLS · Pharma News · Stock Market

Indonesia’s $9B Chinese Fighter Jet Deal Shocks the World

Indonesia’s abrupt pivot to Chinese fighters has captured global attention. Defense analysts say it underscores Jakarta’s insistence on strategic autonomy. “Foreign actors can spread disinformation, but at the end of the day, Indonesia buys what it chooses,” writes analyst Muhammad

18 October 2025

Asia-Pacific · Defense · Geopolitics · International Relations · Military Technology · NYSE:BA · NYSE:LMT

Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics, a clinical-stage biotech developing the RaniPill® capsule for oral delivery of biologic drugs, was essentially flat around $0.45–$0.50 from mid-September through early October. On Oct. 17, it announced a collaboration with Chugai (which is majority-owned by Roche reuters.com)

18 October 2025

Biotech News · Company Collaborations · Investment Analysis · NASDAQ:RANI · Pharmaceuticals · Stock Market